Citadel Advisors »

Neurosense Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $44k 34k 1.27
2023-09-30 $8.8k 12k 0.75
2021-12-31 $135k 55k 2.45

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Neurosense Therapeutics

Armistice Capital
Cantor Fitzgerald, L. P.
Meitav Dash Investments
Citadel Advisors
Commonwealth Equity Services
Geode Capital Management
Morgan Stanley
CWM
Qube Research & Technologies

View all funds holding Neurosense Therapeutics